Skip to main content

Table 1 Characteristics of the Segments

From: Can cluster analyses of linked healthcare data identify unique population segments in a general practice-registered population?

 

Segments

ANOVA or Kruskal-

Wallis/χ2 test

1

2

3

4

5

6

7

8

9

10

Population value

 

Care Utilisation, mean (SD)

 Non-elective inpatient admissions

0.01 (0.1)z

0.17 (0.41)x

1.27 (0.54)x

3.27 (1.68)x

0.02 (0.15)y

0.34 (0.55)x

0.35 (0.69)x

0.02 (0.13)

1.25 (1.29)x

0 (0)z

0.14 (0.52)

KW: < 0.000

 Elective inpatient admissions

0 (0)

1.22 (0.54)x

0.03 (0.16)x

0.36 (0.65)x

0 (0)

0.14 (0.36)y

0.1 (0.37)y

0 (0)

0.14 (0.43)z

0 (0.02)

0.08 (0.34)

KW: < 0.000

 Outpatient first attendances

0 (0)x

0.87 (0.88)y

0.39 (0.6)x

1.79 (1.82)x

1.23 (0.52)y

1.89 (1.19)y

1.26 (1.17)y

0.17 (0.39)x

0.92 (1.13)y

0.09 (0.3)x

0.34 (0.72)

KW: < 0.000

 Outpatient follow-up attendances

0.14 (0.71)x

2.02 (2.39)x

1.17 (1.85)y

4.22 (4.69)y

1.17 (1.92)y

3.66 (3.03)y

20.53 (12.98)x

0.79 (1.52)x

2.26 (3.96)x

0.26 (0.92)x

0.91 (2.98)

KW: < 0.000

 GP practice visits

0.11 (0.4)x

1.34 (1.56)y

1.3 (1.28)y

4.94 (3.54)x

0.93 (1.06)x

4.6 (2.29)x

1.55 (2.05)z

0.71 (1.02)x

7.55 (3.28)x

0.81 (0.99)x

0.74 (1.51)

KW: < 0.000

 Prescribing (Distinct Drug Count)

1.78 (2.04)x

8.11 (6.39)y

6.65 (5.64)x

15.9 (10.01)z

4.31 (3.61)x

15 (7.92)z

8.28 (7.62)y

12.35 (4.58)z

20.64 (9.23)x

2.61 (2.77)x

4.75 (5.8)

KW: < 0.000

 A&E attendances, mean (SD)

0 (0)x

0.48 (0.81)x

1.52 (1.02)y

5.13 (3.15)x

0.28 (0.49)x

1.13 (1.22)x

0.69 (1.12)x

0.14 (0.39)x

2.04 (1.93)y

1.46 (0.84)x

0.41 (0.95)

KW: < 0.000

Patient characteristics

 Age, mean (SD)

36.2 (21.5)x

53.6 (20.5)x

38.2 (27.9)x

47.5 (27.3)x

42.9 (23)y

59.3 (21.4)y

42.1 (20.3)y

60.4 (18.5)y

82.1 (11.1)x

29.8 (20)x

41.4 (23.7)

AN: < 0.000

 Quintile 1 & 2 Deprivation, %

84.2

85.7

87.6

88.6

85.0

85.2

86.5

86.1

78.5z

85.6

85.0

χ2: < 0.000

 Current smoker, %

20.3

23.1

22.3

27.2

22.1

22.1

28.0

25.9z

12.8x

20.6

21.6

χ2: < 0.000

 Risk of emergency admission in next 12 months, mean (SD)

0.07 (0.05)x

0.27 (0.13)x

0.23 (0.14)y

0.45 (0.19)

0.2 (0.1)y

0.38 (0.15)

0.36 (0.16)z

0.24 (0.12)x

0.5 (0.17)z

0.12 (0.08)x

0.15 (0.13)

AN: < 0.000

Long Term Conditions (LTCs)

 Number of LTCs, mean (SD)

0.58 (0.92)y

2.55 (2.36)x

2.08 (2.44)x

5.27 (4.03)y

1.22 (1.46)x

3.75 (2.68)y

2.31 (2.45)x

2.89 (1.95)x

6.46 (3.39)x

0.64 (1)y

1.32 (1.9)

KW: < 0.000

 Long Term Condition, prevalence in %

  ARMD

0.2y

1.6

0.9z

1.9

0.7z

2.8z

2.2

1.9

9.0x

0.2z

0.7

χ2: < 0.000

  Arthritis

0.2z

1.2

1.2

2.6z

0.8

5.0y

1.2

2.4z

5.7y

0.3z

0.9

χ2: < 0.000

  Asthma

7.1y

15.7

13.6

24.6z

10.3z

21.3z

16.2

21.9z

11.8

9.6z

11.0

χ2: < 0.000

  Bipolar Disorder

0.1z

0.4

0.5

2.7z

0.4

1.3z

2.5z

0.8

1.4

0.1

0.4

χ2: < 0.000

  CHF

0.1z

1.8z

2.1

8.4x

0.5z

4.8x

2.2

2.6z

14.9x

0.1z

1.0

χ2: < 0.000

  COPD

0.7y

7.1z

6.3z

20.6x

2.0x

12.9y

6.5z

12.2y

30.7x

0.5y

3.6

χ2: < 0.000

  CRF

1.1y

6.7z

5.7z

15.7y

3.2y

13.1y

5.6

10.8x

31.0x

0.8y

3.8

χ2: < 0.000

  Depression

6.8x

15.4

13.5

28.7y

11.9y

17.7

17.2

16.8

22.0

8.5x

10.3

χ2: < 0.000

  Diabetes

2.1y

11.7y

8.2x

21.7

5.3x

25.4

13.3y

24.9

24.8

1.9y

7.1

χ2: < 0.000

  Glaucoma

0.5y

3.4

1.5

2.8

1.3

4.5y

2.0

3.2

9.5x

0.3y

1.3

χ2: < 0.000

  Hypertension

9.5x

33.4x

22.8y

39.2x

17.8y

46.6x

21.0z

49.5x

68.1x

7.2x

18.9

χ2: < 0.000

  Hyperthyroidism

1.8y

7.4y

4.9z

11.1z

4.1z

11.7z

5.2

11.5z

17.5x

1.6y

4.2

χ2: < 0.000

  Ischaemic Heart Ds

0.6y

7.6z

6.8z

19.8y

2.6y

17.5y

5.1

11.7x

30.0x

0.8y

3.8

χ2: < 0.000

  Low Back Pain

1.1y

5.1

3.6

8.8y

2.2z

5.8z

2.8

4.4

5.4

2.0z

2.3

χ2: < 0.000

  Osteoporosis

0.0z

0.8z

1.4y

5.8y

0.3

2.1x

0.7

0.4

7.1y

0.0

0.4

χ2: < 0.000

  Parkinson’s Ds.

0.0

0.1

0.4

1.1

0.3

1.1y

0.2

0.5

5.0x

0.0

0.2

χ2: < 0.000

  Schizophrenia

0.4z

0.8

1.6z

4.6y

0.9z

2.3y

10.7x

1.3

4.5y

0.3z

0.9

χ2: < 0.000

  Seizure Disorder

0.8

2.1z

4.0z

10.4x

1.2

3.4

2.2

3.0

4.7

1.3

1.6

χ2: < 0.000

  1. Significantly different from all 9 other segments; y: Significantly different from 8 other segments; z: Significantly different from 7 other segments; All at 0.05/9 = 0.0056 significance level (Bonferroni adjustment). All variables are significantly different across segments at a < 0.000 significance level using ANOVA, Kruskal-Wallis or Chi Square tests; ARMD – Age-Related Macular Degeneration; CHF – Congestive Heart Failure; COPD – Chronic Obstructive Pulmonary Disease; CRF – Chronic Renal Failure